Showing results (1881-1890 of 1,899) with videos related to
Sort By:
Pageof 190
Immunotherapy|August 6, 2020
Peptide vaccine with glucopyranosyl lipid A-stable oil-in-water emulsion for patients with resected melanomaEric P Grewal, Courtney L Erskine, Wendy K Nevala, et al.Immunotherapy|December 22, 2012
A systematic review of biologics for the treatment of noninfectious uveitisMasaru TakeuchiImmunotherapy|July 10, 2026
The dual legacy of BCG: a century of tuberculosis prevention and the evolving pursuit of trained immunity-based therapiesNazeer Ahmed, Fatima Jawaid, Muhammad NabeelImmunotherapy|July 6, 2026
The skin microbiome-immune-barrier axis: implications for inflammatory skin disorders and immunotherapeutic strategiesShreyashree Mohanty, Pratikeswar Panda, Rajaram MohapatraImmunotherapy|March 19, 2026
Advances in immunotherapy for cytomegalovirus infection following allogeneic hematopoietic stem cell transplantationYu Wang, Jiaying Wu, Xiaobing Huang, et al.Immunotherapy|March 28, 2026
Efficacy and safety of tarlatamab, a DLL3-targeted bispecific T-cell engager, in a patient with advanced esophageal small-cell neuroendocrine carcinoma: a case reportBahadır Köylü, Cevat İlteriş Kıkılı, Fatih Kemik, et al.Immunotherapy|August 10, 2026
Cost-effectiveness analysis of Nivolumab plus Ipilimumab versus Nivolumab monotherapy in previously treated metastatic colorectal cancer patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) in ChinaXiaohong Zhu, Xu Yang, Tong LiuImmunotherapy|September 5, 2026
Cancer vaccines as targeted therapies: translational advances and challengesZahra Shafaghat, Maryam Sadri, Mona Roozbehani, et al.Immunotherapy|September 7, 2026
Bromodomain inhibitors in autoimmune diseasesMarcin Szczepanik, Wojciech Pociej, Joanna Kulpa, et al.Immunotherapy|September 2, 2026
Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinomaCaner Kapar, Oğuzcan Özkan, Eda Eylemer Mocan, et al.Pageof 190